NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Screening for Hypertension in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force
Evidence Synthesis, No. 197
Investigators: Janelle M. Guirguis-Blake, MD, Corinne V. Evans, MPP, Elizabeth M. Webber, MS, Erin L. Coppola, MPH, Leslie A. Perdue, MPH, and Meghan Soulsby Weyrich, MPH.
Structured Abstract
Objective:
We conducted this systematic review to support the U.S. Preventive Services Task Force (USPSTF) in updating its recommendation on screening for hypertension in adults. This systematic review addresses the benefits and harms of screening for hypertension in adults, including the accuracy of initial office-based screening measurements during a single encounter and confirmatory blood pressure measurements using various modalities in those who initially screen positive.
Data Sources:
We performed a search of MEDLINE, PubMed (publisher-supplied records only), the Cochrane Collaboration Registry of Controlled Trials, and the Cumulative Index of Nursing and Allied Health for relevant English-language studies published between February 2014, and August 2019. Additionally, we re-evaluated all studies included in the 2014 USPSTF review. We supplemented searches by examining bibliographies from retrieved articles and consulting outside experts. We searched clinical trial registries for ongoing and/or unpublished trials. We conducted ongoing surveillance for relevant literature through March 26, 2021.
Study Selection:
Two investigators independently reviewed 21,741 abstracts and 544 full-text articles against a set of a priori inclusion and quality criteria. Resolution of disagreements was achieved through discussion with a third reviewer. We included the following study designs: randomized controlled trials (RCTs) and clinical controlled trials (CCTs) for effectiveness of screening (KQ1); test accuracy studies for accuracy of initial office-based blood pressure screening (KQ2) and subsequent confirmatory blood pressure measurements (KQ3) using an ambulatory blood pressure measurement (ABPM) reference standard; and RCTs, CCTs, and cohort and cross-sectional studies for screening and confirmation harms (KQ4).
Data Analysis:
One investigator abstracted data into evidence tables and a second investigator checked accuracy. We qualitatively synthesized data separately for each key question. We meta-analyzed study results for Key Questions 2 and 3. Our quantitative analyses utilized a bivariate model for sensitivity and specificity outcomes. We used visual inspection of forest plots arranged by various study, population, and test characteristics to explore heterogeneity.
Results:
For KQ1, one community-based cluster RCT (N=140,642) of a multicomponent CVD health promotion program that included hypertension screening as the primary intervention for older adults reported a 9 percent relative reduction in composite CVD-related hospital admissions (rate ratio 0.91 [95% CI, 0.86 to 0.97]). For KQ2, meta-analysis of 15 studies (N=11,309) of office-based blood pressure measurement (OBPM) for screening at a single visit demonstrated a pooled sensitivity of 0.54 (95% CI, 0.37 to 0.70) and a pooled specificity of 0.90 (95% CI, 0.84 to 0.95) with considerable clinical and statistical heterogeneity. For KQ3, 18 studies (N=57,128) of various confirmatory blood pressure measurement modalities reported data that allowed accuracy calculations; these studies used confirmation modalities of: OBPM, home blood pressure measurement (HBPM), self-OBPM (measurement performed by a patient in the office setting), and truncated ABPM. Meta-analysis of eight OBPM confirmation studies (N=53,183) showed a pooled sensitivity of 0.80 (95% CI, 0.68 to 0.88) and a pooled specificity of 0.55 (95% CI, 0.42 to 0.66) with considerable clinical and statistical heterogeneity. Meta-analysis of four HBPM confirmation studies (N=1,001) showed a pooled sensitivity of 0.84 (95% CI, 0.76 to 0.90) and a pooled specificity of 0.60 (95% CI, 0.48 to 0.71) with considerable statistical heterogeneity. Two studies of self-OBPM (N=698) and one study of truncated ABPM (N=263) provided a limited evidence base for determination of accuracy for these modalities. There was limited information about the accuracy of protocol variations, precluding conclusions about the optimal protocol characteristics for screening and confirmatory blood pressure measurement in the included studies. For KQ4, 13 studies (N=5,150) suggest that screening is associated with no decrements in quality of life or psychological distress and scant evidence on screening’s effect on absenteeism is mixed. ABPM followup testing is associated with minor adverse events including temporary sleep disturbance and bruising.
Limitations:
The literature identified for blood pressure screening and confirmation accuracy represented a heterogeneous group of studies resulting in inconsistent and imprecise accuracy estimates. The included protocol characteristics for screening and confirmatory blood pressure measurements likely represent “research quality” measures not followed in current practice.
Conclusions:
Blood pressure screening at a single visit has a low sensitivity and adequate specificity for detection of hypertension, leading to a substantial number of potentially missed cases. Confirmatory office or home blood pressure measurement applied to a population with a previously elevated blood pressure has adequate sensitivity and low specificity suggesting that these modalities may not be appropriate replacements for ABPM for diagnostic confirmation. Scant literature is available to inform best practices in blood pressure measurement to optimize test accuracy. Limited available evidence on the direct harms of screening and confirmatory blood pressure measurements suggest that the harms are minimal, and the most notable harm of blood pressure screening is likely misdiagnosis with ensuant under or over-treatment. Future research is needed to identify optimal blood pressure measurement protocols and confirmation algorithms—including blood pressure threshold values—to inform clinical practice.
Contents
- Acknowledgments
- Chapter 1. Introduction
- Chapter 2. Methods
- Chapter 3. Results
- Literature Search
- KQ1. Does Screening for Hypertension in Adults Improve Health Outcomes?
- KQ2. What Is the Accuracy of OBPM During a Single Encounter as Initial Screening for Hypertension Compared With the Reference Standard, ABPM?
- KQ2a. What Screening Protocol Characteristics Define the Best Test Accuracy?
- KQ3. What Is the Accuracy of Confirmatory Blood Pressure Measurement in Adults Who Initially Screen Positive for Hypertension Compared With the Reference Standard (ABPM)?
- KQ3a. What Confirmation Protocol Characteristics Define the Best Test Accuracy?
- KQ4. What Are the Harms of Screening for Hypertension in Adults?
- Chapter 4. Discussion
- Summary of Evidence
- Comparison to Results of Other Systematic Reviews
- Understanding the Clinical Relevance of Test Accuracy of Screening and Confirmatory Testing
- White Coat and Masked Hypertension
- Rescreening
- AOBP
- Limitations of Our Approach
- Limitations of the Studies, Ongoing Research, and Future Research Needs
- Conclusions
- References
- Appendixes
Suggested citation:
Guirguis-Blake JM, Evans CV, Webber EM, Coppola EL, Perdue LA, Soulsby Weyrich M. Screening for Hypertension in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis No. 197. AHRQ Publication No. 20-05265-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2021.
This report is based on research conducted by the Kaiser Permanente Research Affiliates Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (HHSA-290-2015-000017-I-EPC5). The findings and conclusions in this document are those of the authors, who are responsible for its contents, and do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help healthcare decision makers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of healthcare services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information (i.e., in the context of available resources and circumstances presented by individual patients).
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
- NLM CatalogRelated NLM Catalog Entries
- Review Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2014]Review Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task ForcePiper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Smith N, Webber E, Perdue LA, Bigler KD, Whitlock EP. 2014 Dec
- Review Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force[ 2020]Review Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task ForcePatnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, Lin JS. 2020 Feb
- Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force[ 2018]Review Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task ForceLeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. 2018 Sep
- Review Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task Force[ 2018]Review Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task ForceLin JS, Evans CV, Johnson E, Redmond N, Burda BU, Coppola EL, Smith N. 2018 Jul
- Review Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force[ 2014]Review Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task ForceHenderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG. 2014 Apr
- Screening for Hypertension in Adults: An Updated Systematic Evidence Review for ...Screening for Hypertension in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force
Your browsing activity is empty.
Activity recording is turned off.
See more...